EATONTOWN, N.J., Oct. 6 /PRNewswire/ -- Osteotech, Inc. (Nasdaq:
OSTE), a leader in the emerging field of biologic products for
regenerative healing, announced today that a record date and a
special meeting date have been established for Osteotech's
stockholders to vote on the proposal to adopt the previously
announced merger agreement by and among Osteotech, Medtronic, Inc.
("Medtronic"), Medtronic Sofamor Danek, Inc., a wholly owned direct
subsidiary of Medtronic ("MSD"), and England Merger Corporation, a
wholly owned direct subsidiary of MSD ("Merger Sub"). The
merger agreement provides that Merger Sub will be merged with and
into Osteotech, with Osteotech continuing as the surviving
corporation, and becoming a wholly owned subsidiary of MSD and a
wholly owned indirect subsidiary of Medtronic.
Osteotech stockholders of record at the close of business on
October 8, 2010 will be entitled to
notice of the special meeting and to vote on the adoption of the
merger agreement. The special meeting is scheduled to be held
on Tuesday, November 9, 2010 at
9:00 a.m. Eastern Time at Osteotech's
corporate office located at 51 James Way, Eatontown, New Jersey. The definitive
proxy statement for the special meeting will be filed with the
Securities and Exchange Commission and first mailed to stockholders
on or about October 14, 2010.
About Osteotech
Osteotech, Inc., headquartered in Eatontown, New Jersey, is a global leader in
providing biologic solutions for regenerative medicine to support
surgeons and their patients in the repair of the musculoskeletal
system through the development of innovative therapy-driven
products that alleviate pain, promote biologic healing and restore
function. For further information regarding Osteotech, please
go to Osteotech's website at www.osteotech.com.
Additional Information about the Proposed Transaction and
Where You Can Find It
Osteotech intends to file with the Securities and Exchange
Commission (the "SEC") a definitive proxy statement and other
relevant materials in connection with the proposed acquisition of
Osteotech by Medtronic. The definitive proxy statement will
be mailed to Osteotech stockholders. Before making any voting
or investment decisions with respect to the transaction, investors
and stockholders of Osteotech are urged to read the proxy statement
and the other relevant materials when they become available because
they will contain important information about the transaction,
Osteotech and Medtronic. Investors and stockholders may
obtain free copies of these documents (when they are available) and
other documents filed with the SEC at the SEC's web site at
www.sec.gov. In addition, investors and stockholders may
obtain free copies of the documents filed with the SEC by accessing
Osteotech's website at www.osteotech.com or by writing Osteotech to
the attention of the Assistant Secretary at 51 James Way,
Eatontown, New Jersey, 07724.
Information Regarding Participants
Osteotech, Medtronic and their respective directors, executive
officers and certain other members of management and employees may
be soliciting proxies from Osteotech stockholders in favor of the
merger. Information regarding the persons who may, under the
rules of the SEC, be considered participants in the solicitation of
the Osteotech stockholders in connection with the proposed merger
will be set forth in the proxy statement when it is filed with the
SEC. You can find information about Medtronic's executive
officers and directors in its definitive proxy statement filed with
the SEC on July 16, 2010. You
can obtain a free copy of this document at the SEC's web site at
www.sec.gov, or by accessing Medtronics's website at
www.Medtronic.com and clicking on the Investors link. You can
find information about Osteotech's executive officers and directors
in its definitive proxy statement filed with the SEC August 3, 2010. You can obtain a free copy
of this document at the SEC's web site at www.sec.gov or by
accessing Osteotech's website at www.osteotech.com or by writing
Osteotech to the attention of the Assistant Secretary at 51 James
Way, Eatontown, New Jersey, 07724.
SOURCE Osteotech, Inc.
Copyright t. 6 PR Newswire